CapSen Robotics achieves state-of-the-art results on one of the most pressing problems in robotics and 3D computer vision—correctly identifying and locating specific objects in clutter. This breakthrough makes it possible to provide a general computer vision solution for manufacturing applications such as bin picking as well as warehouse automation tasks such as order fulfillment or inventory management. There long-term goal is to provide a universal 3D computer vision system that enables the robots of the future to see and understand the physical world.
Carmell Therapeutics Corporation
Carmell has developed a method of manufacturing biologically-active plastic materials from blood plasma. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell is focused on products for the sports medicine market with devices for the repair of tendon and cartilage injuries.
Carnegie Speech Company, Inc.
Carnegie Speech Company is the premier developer and provider of software for assessing and teaching spoken-language skills. Using speech recognition and artificial technologies licensed from Carnegie Mellon University, Carnegie Speech software enables personalized, cost-effective and scalable spoken-language assessment and training. With years of linguistic research, world-class technology and language tutoring expertise, Carnegie Speech provides spoken-language training software to a worldwide clientele in the Corporate Training/BPO, Government, Aviation, Education and Health Care sectors.
Cassian offers premier patient engagement tools that transform the manual labor of patient outreach into a seamless and automated process. The company’s hardware and software platform enables data-driven patient interactions efficiently at any scale
Cell X Technologies
Cell X Technologies, Inc. is on a mission to industrialize the development and manufacturing of regenerative medicines by automating manual processes and decision-making. Our software, robotics, and machine learning/AI platform deepens scientific understanding, improves reproducibility, and identifies product quality metrics needed to commercialize these lifesaving therapies. Our platform reacts to the biology of the cells to produce a robust, automated process.
Cellumen, Inc. (Acquired by Apredica/Cyprotex)
Cellumen is the Systems Cell Biology company that is focused on delivering cellular models of disease and cytotoxicity that will revolutionize the drug discovery process and improve the quality of compounds entering clinical trials. The same systems cell biology approach is also being developed to optimize personalized medicine for clinical trials. Cellumen was acquired by Apredica/Cyprotex 8/4/10.
Cepstral provides speech technologies and services for the spoken delivery of information. We build high quality, natural sounding voices for hand-held, desktop, and server applications. Our technology is easy to incorporate and operates in a small memory footprint with low computing resources. In contrast with previous technologies, which are either very large systems or offer lower quality due to outdated technology, Cepstral Text-To-Speech (TTS) engines and voices can be deployed on mobile devices or in multiple instances on server platforms, making it the easiest to use and most versatile product available today.